Carles Escriu
4PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Oct 17, 2025
Survival with Osimertinib plus Chemotherapy in EGFR-Mutated Advanced NSCLC.Pasi A Jänne, David Planchard, Kunihiko Kobayashi
|Apr 13, 2024
Intracranial Efficacy of Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel in Real-World Patients with Non-Small-Cell Lung Cancer and EGFR or ALK Alterations.Marcus Rathbone, Conor O'Hagan, Helen Wong
|Jul 19, 2021
Neoadjuvant osimertinib with/without chemotherapy versus chemotherapy alone for EGFR-mutated resectable non-small-cell lung cancer: NeoADAURA.Masahiro Tsuboi, Walter Weder, Carles Escriu
|Nov 03, 2019
Treatment beyond four cycles of first line Platinum and Etoposide chemotherapy in real-life patients with stage IV Small Cell Lung Cancer: a retrospective study of the Merseyside and Cheshire Cancer network.Mostafa Sallam, Helen Wong, Carles Escriu
Pageof 1
